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542a Tuesday, February 18, 2014these residues play a specific role in lowering the transition state energy barrier
between open and closed channel states. The demonstration of a negative
phi-value is unique for an ion channel gating process, and diverges from inter-
pretations that use phi-values to place specific residues in the spatial and tem-
poral progression through the transition energy landscape. Using nonsense
suppression for unnatural amino acid incorporation, we demonstrate the
requirement for a planar amino acid at Kir6.2 position 68, potentially required
to localize the ε-amine of Lys170 in the PIP2 binding site. Our findings identify
a discrete pair of residues with an essential role for controlling gating kinetics
of Kir channels.
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Inspection of the architecture of Kir channels reveals a non-covalent interface
between the ’ligand-sensing’ C-terminal domain (CTD) and the canonical pore-
forming ’gating domain’ formed by the TM1 and TM2 transmembrane helices.
This interface is involved in transduction of ligand binding, and intact coupling
between the CTD and TMD of Kir6.2 channels has been proposed to be crucial
for propagation of gating effects induced by intracellular ligands. However,
many mutations in this interfacial region prevent channel function and thereby
preclude functional studies to interrogate the domain interface. We have devel-
oped a novel rescue mechanism that circumvents this problem, and we have
applied this method to scan the functional contributions of residues in the
CTD-TMD interface of Kir6.2 channels. Overall, residues cluster into three
distinct functional types, based on their impact on ATP sensitivity and gating
kinetics of the F168E background mutation used for functional rescue. Most
loss-of-function mutations are classified as ’efficiently coupled’, and their
ATP sensitivity is only modestly affected by introduction of mutations. A sec-
ond group of mutations comprises residues in the ATP binding site, which
are ’efficiently coupled’ but are profoundly insensitive to ATP. Most interest-
ingly, our studies reveal a subset of ’uncoupling’ mutations that form a network
between the C-linker, G-loop, C-D loop, and slide helix of the channel. These
residues exhibit an unusual combination of low open probability (or complete
loss of function) combined with profound ATP insensitivity. The identification
of mutations that uncouple the TMD and CTD distinguishes unique gating
roles for residues that are required for channel function, and highlights the
importance of a rescue approach to understand the impact of loss of function
mutations.
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The b-cell ATP-sensitive potassium (KATP) channel regulates insulin secre-
tion by coupling glucose metabolism to membrane excitability. Mutations in
the constituent protein subunits Kir6.2 and sulfonylurea receptor 1 (SUR1)
that prevent channels from trafficking to the cell surface are frequent causes
of congenital hyperinsulinism. We recently reported that carbamazepine, an
anticonvulsant, corrects the trafficking defects caused by mutations in the
N-terminal transmembrane domain of SUR1. In addition, carbamazepine in-
hibits the function of rescued channels that can be reversed by subsequent
drug removal. Here, we investigated the mechanism underlying carbamaze-
pine’s effects on KATP channel trafficking and gating by partial proteolysis
and electrophysiology, respectively. We show that carbamazepine inhibits
channel activity by specifically abolishing channel response to the physiolog-
ical stimulator MgADP. Our partial proteolysis results show that carbamaze-
pine interacts with the channel complex and protects the N-terminus of
Kir6.2 against trypsin digestion. Further, results show that deletion of Kir6.2
N-terminal 30 amino acids severely compromised carbamazepine mediated
rescue of the SUR1 trafficking mutant, F27S. Our findings suggest a structural
model for carbamazepine mediated rescue of SUR1-TMD0 trafficking mutants
and inhibition of KATP channels.
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PA, USA.The conductance of potassium channels can be regulated by C-type inactiva-
tion, which consists in the time-dependent closing of their selectivity filter
following activation. Crystallization of the KcsA channel from S. lividans
under conditions of low potassium concentration revealed conformational
changes of the selectivity filter preventing the permeation of both K and Na
ions. This structure was associated with the C-type inactivated state of K
channels. Under similar low potassium crystallization conditions, MthK
from M. thermoautotrophicum, another model potassium channel, remains
in its canonical conductive state. Functional studies nevertheless show that
MthK undergo C-type inactivation like KcsA. In KcsA, the transition to the
inactivated state is favored by a glutamate in the vicinity of the selectivity
filter (Glu71). Mutation of this residue to alanine decreases inactivation dras-
tically. Our electrophysiology and molecular simulation data show that, in
MthK, a mutation of a valine at the same position to a glutamate (V55E)
accelerates inactivation and results in a conformation of the selectivity filter
similar to the inactivated state of KcsA. These results support the idea that
potassium channels can potentially adopt two different inactivated states.
We further investigate changes in ion binding affinity in MthK and KcsA
channel mutants to understand the underlying difference in inactivation
behavior using molecular dynamic simulations, free energy calculations and
electrophysiological measurements.
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The intermediate-conductance KCa3.1 channel and the related small-
conductance KCa2 channels constitute potential pharmacological targets for
immunosuppression, fibroproliferative disorders, hypertension and various
neurological diseases. However, there currently is no available crystal structure
or molecular model of these medically relevant targets that could be used for
structure-assisted drug design. We used the Kv1.2-Kv2.1 channel structure
(pdb id: 2R9R) as a template to generate a homology model of the KCa3.1
channel transmembrane region with the Rosetta modeling method. Docking
of small molecules that are known to block KCa3.1 channel currents using
Rosetta Dock generated structural channel - drug complexes that can be vali-
dated using experimental approaches. The lowest energy confirmation of the
KCa3.1 channel complex with TRAM-34 identified T250 and V275 as interac-
tion sites, two residues which had been previously demonstrated to completely
abolish triarylmethane sensitivity when mutated to the corresponding residues
in KCa2.3 channel. The model further correctly identified the interaction of the
benzothiazinone-type KCa3.1 channel blocker NS6180 with T250 and V275 in
KCa3.1 channel and modeled binding of the negative KCa2 channel gating
modulator NS8593 to a KCa3.1-T250S- V275A mutant channel, which is
blocked more potently by NS8593 than the WT-KCa2.3 channel. For the dihy-
dropyridine nifedipine, which blocks KCa3.1 channels with low micromolar
activity, the Rosetta model suggested a receptor site located between the
pore lining S5 and S6 segment in agreement with available experimental
data showing that nifedipine does not interact with T250 in the selectivity filter.
The Rosetta KCa2/3 channel models can be used to understand the molecular
mechanism of action of KCa channel blockers and gating modulators and assist
with drug design efforts. Supported by RO1 GM076063 (to H.W.) and UC
Davis startup (to V.Y-Y.).
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The intermediate-conductance Ca2þ-activated Kþ channel KCa3.1 (also known
as KCNN4, IK1 or the Ga´rdos channel) plays an important role in the
activation of T- and B-cells, mast cells, macrophages and microglia by regu-
lating membrane potential, cellular volume and calcium signaling. KCa3.1
is further involved in the proliferation of dedifferentiated vascular smooth
muscle cells and fibroblast and endothelium-derived hyperpolarization
(EDH) responses in the vascular endothelium. Accordingly, KCa3.1 inhibitors
are therapeutically interesting as immunosuppressants and for the treatment
of a wide range of fibroproliferative disorder, while KCa3.1 activators
constitute a potential new class of endothelial function preserving antihyper-
tensives. Here, we report the development of QPatch assays for both
KCa3.1 inhibitors and activators. During assay optimization, the Ca2þ sensi-
tivity of KCa3.1 was studied using varying intracellular Ca2þ concentrations.
A free Ca2þ concentration of 1 mM was chosen to optimally test inhibitors.
